Skip to main content

International Journal of Hematology

Ausgabe 4/2015

Inhalt (19 Artikel)

Images in Hematology

Sepsis in newborn: phagocytosis by peripheral blood neutrophils and monocytes

Denise Rezende, Valéria Salgado, Mayara Caldas Ramos, Ricardo Ambrósio Fock

Images in Hematology

Visceral leishmaniasis in relapsed and overtreated multiple myeloma in the era of high dose and “novel agent” therapy

Lorenza Torti, Stefano Pulini, Anna Maria Morelli, Francesco Bacci, Paolo Di Bartolomeo

Original Article

Serum BAFF and APRIL levels in patients with autoimmune hemolytic anemia and their clinical significance

Zi-Zhen Xu, Bing-Bing Zhao, Hong Xiong, Bei-Wen Wei, Ye-Fei Wang

Original Article

A randomized controlled trial comparing darbepoetin alfa doses in red blood cell transfusion-dependent patients with low- or intermediate-1 risk myelodysplastic syndromes

Jun Ho Jang, Hironori Harada, Hirohiko Shibayama, Ryutaro Shimazaki, Hyeoung-Joon Kim, Kenichi Sawada, Kinuko Mitani

Original Article

Disseminated intravascular coagulation in non-Hodgkin lymphoma

SungGi Chi, Takayuki Ikezoe

Original Article

Is there role of additional chemotherapy after definitive local treatment for stage I/II marginal zone lymphoma?: Consortium for Improving Survival of Lymphoma (CISL) study

Myeong Seok Koh, Won Seog Kim, Seok Jin Kim, Sung Yong Oh, Dok Hyun Yoon, Soon Il Lee, Junshik Hong, Moo Kon Song, Ho-Jin Shin, Jung Hye Kwon, Hyo Jung Kim, Yong Rok Do, Cheolwon Suh, Hyo Jin Kim

Original Article

The longitudinal analysis of large granular lymphocytosis in patients with Philadelphia chromosome-positive leukemia treated with dasatinib

Yuji Shimura, Shigeo Horiike, Yasuhiko Tsutsumi, Mayumi Hatsuse, Akira Okano, Shin-ichi Fuchida, Tsutomu Kobayashi, Yosuke Matsumoto, Junya Kuroda, Eri Kawata-Iida, Hitoji Uchiyama, Nobuhiko Uoshima, Chihiro Shimazaki, Hiroto Kaneko, Yutaka Kobayashi, Masafumi Taniwaki

Original Article

Phase I dose-escalation study of cyclophosphamide combined with bortezomib and dexamethasone in Japanese patients with relapsed and/or refractory multiple myeloma

Isamu Sugiura, Satomi Terabe, Tomohiro Kinoshita, Kazuhito Yamamoto, Masashi Sawa, Yukiyasu Ozawa, Yoshiko Atsuta, Ritsuro Suzuki, Kazuyuki Shimizu

Original Article

Oncogenic microRNA-155 and its target PU.1: an integrative gene expression study in six of the most prevalent lymphomas

Hana Huskova, Katarina Korecka, Josef Karban, Jarmila Vargova, Karina Vargova, Nina Dusilkova, Marek Trneny, Tomas Stopka

Original Article

Clinical significance of the administration of cytarabine or thiotepa in addition to total body irradiation and cyclophosphamide for allogeneic hematopoietic cell transplantation in patients with acute leukemia

Takayoshi Tachibana, Masatsugu Tanaka, Maki Hagihara, Rika Kawasaki, Etsuko Yamazaki, Hideyuki Koharazawa, Jun Taguchi, Naoto Tomita, Katsumichi Fujimaki, Rika Sakai, Hiroyuki Fujita, Shin Fujisawa, Atsuo Maruta, Yoshiaki Ishigatsubo, Heiwa Kanamori

Original Article

A donor thrombomodulin gene variation predicts graft-versus-host disease development and mortality after bone marrow transplantation

Haruka Nomoto, Akiyoshi Takami, J. Luis Espinoza, Keitaro Matsuo, Shohei Mizuno, Makoto Onizuka, Koichi Kashiwase, Yasuo Morishima, Takahiro Fukuda, Yoshihisa Kodera, Noriko Doki, Koichi Miyamura, Takehiko Mori, Shinji Nakao, Shigeki Ohtake, Eriko Morishita

Case Report

Identification of anti-thrombopoietin receptor antibody in prolonged thrombocytopenia after allogeneic hematopoietic stem cell transplantation treated successfully with eltrombopag

Akihito Fujimi, Yusuke Kamihara, Akari Hashimoto, Yuji Kanisawa, Chisa Nakajima, Naotaka Hayasaka, Shota Yamada, Toshinori Okuda, Shinya Minami, Kaoru Ono, Satoshi Iyama, Junji Kato

Case Report

Adult-onset congenital thrombotic thrombocytopenic purpura caused by a novel compound heterozygous mutation of the ADAMTS13 gene

Johannes G. Krabbe, Evelien W. M. Kemna, Annuska L. M. Strunk, Pieter A. Jobse, P. A. Kramer, L. D. Dikkeschei, L. P. W. J. van den Heuvel, Rob Fijnheer, Leo F. Verdonck

Case Report

Epstein–Barr virus-positive diffuse large B-cell lymphoma following acute myeloid leukemia: a common clonal origin indicated by chromosomal translocation t(3;4)(p25;q21)

Masakazu Higuchi, Shoichi Sasaki, Shin-ichiro Kawadoko, Hikaru Uchiyama, Takaharu Yasui, Takashi Kamihira, Ken-ichi Aoki, Takakazu Sasaguri, Ryuji Nakano, Akihiko Uchiyama, Tsuyoshi Muta, Koichi Ohshima

Case Report

Synergistic defects of UNC13D and AP3B1 leading to adult hemophagocytic lymphohistiocytosis

Lili Gao, Lijun Zhu, Liang Huang, Jianfeng Zhou

Case Report

Colitis mimicking graft-versus-host disease during treatment with the anti-CCR4 monoclonal antibody, mogamulizumab

Kenji Ishitsuka, Mutsunori Murahashi, Hiroo Katsuya, Ai Mogi, Michio Masaki, Chisato Kawai, Toshitaka Goto, Masanao Ishizu, Yosuke Ikari, Yasushi Takamatsu, Hideki Ishibashi, Satoshi Nimura, Morishige Takeshita, Kazuo Tamura

Case Report

Persistent complete remission of acute leukemic-phase CCR4-positive gamma–delta peripheral T-cell lymphoma by autologous stem cell transplantation with mogamulizumab

Miki Furukawa, Kazuhiko Ikeda, Hiroshi Ohkawara, Shunichi Saito, Hiroshi Takahashi, Koki Udea, Hayato Matsumoto, Yuko Hashimoto, Hitoshi Ohto, Kazuei Ogawa, Yasuchika Takeishi

Erratum

Erratum to: Infusion of donor lymphocytes expressing the herpes simplex virus thymidine kinase suicide gene for recurrent hematologic malignancies after allogeneic hematopoietic stem cell transplantation

Hisayoshi Hashimoto, Shigehisa Kitano, Ryosuke Ueda, Ayumu Ito, Kohei Tada, Shigeo Fuji, Sung-Won Kim, Takuya Yamashita, Daisuke Tomura, Ikuei Nukaya, Junichi Mineno, Takahiro Fukuda, Shinichiro Mori, Yoichi Takaue, Yuji Heike

Erratum

Erratum to: A donor thrombomodulin gene variation predicts graft-versus-host disease development and mortality after bone marrow transplantation

Haruka Nomoto, Akiyoshi Takami, J. Luis Espinoza, Keitaro Matsuo, Shohei Mizuno, Makoto Onizuka, Koichi Kashiwase, Yasuo Morishima, Takahiro Fukuda, Yoshihisa Kodera, Noriko Doki, Koichi Miyamura, Takehiko Mori, Shinji Nakao, Shigeki Ohtake, Eriko Morishita

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.